Antibody-based therapies for infectious diseases: Renaissance for an abandoned arsenal?

Arturo Casadevall, D. L. Goldman, M. Feldmesser

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Antibody-based therapies were largely abandoned with the advent of antimicrobial chemotherapy but now are the subject of increasing interest. Two developments contributing to a renaissance in antibody-based therapies are advances in the technology of antibody production and the difficulties involved in treating infections with conventional chemotherapy.

Original languageEnglish (US)
Pages (from-to)247-257
Number of pages11
JournalBulletin de l'Institut Pasteur
Issue number4
StatePublished - Jan 1 1997


  • Antibiotic resistance
  • HIV
  • Immunoglobulin
  • Opportunistic infection
  • RSV
  • Review
  • Septic shock
  • Therapeutics

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology


Dive into the research topics of 'Antibody-based therapies for infectious diseases: Renaissance for an abandoned arsenal?'. Together they form a unique fingerprint.

Cite this